Cora or Ro Body? A 2026 GLP-1 cost breakdown

Cora Health vs Ro: the short answer

How much does Ro cost per month? As of September 27, 2026, Ro charges two separate things. The first is the Ro Body membership: $39 for the first month, then $149/month on the monthly plan, $99/month prepaid every 3 months, $89/month prepaid every 6 months, or $74/month prepaid annually. The second is the medication, at cash-pay prices that rise with dose: the Wegovy® pill from $149/month, the Foundayo™ (orforglipron) pill from $149/month, the Wegovy® pen at $199/month for the first two months (a limited-time price at the 0.25 mg and 0.5 mg doses), then $349/month, or $399/month at 7.2 mg, and the Zepbound® KwikPen® from $299/month. On the monthly membership, Ro’s total is $298/month at the lowest entry dose and up to $598/month at the highest Zepbound dose. Ro does not sell compounded GLP-1s; its pricing page lists FDA-approved medications only (checked September 27, 2026). Is Ro FDA-approved? Companies are not FDA-approved; medications are. Every weight-loss medication Ro lists is an FDA-approved brand-name product. Cora Health, by contrast, connects patients with licensed providers at Wasef Health, PC who prescribe compounded semaglutide or compounded tirzepatide when clinically appropriate; compounded medications are not FDA-approved and are not therapeutically equivalent to those products.

Cora Health and Ro (Ro Body) are both US telehealth platforms that connect patients with licensed providers for GLP-1 weight loss treatment, but they sell different kinds of medication: Ro sells FDA-approved brand-name GLP-1s only, and Cora Health’s plans are for compounded semaglutide and compounded tirzepatide. Cora Health charges one all-inclusive plan price that covers the provider consultation, the medication, shipping, and ongoing monitoring; the medication is prepared by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy and VialsRx. Ro bills a membership plus a separate medication charge. Month to month, Ro’s lowest total is $298 (membership plus the Wegovy® pill, an FDA-approved tablet); Cora’s Essential Plan (compounded semaglutide injection) is $175, billed monthly, renews automatically. They are different products: compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Wegovy®. Ro’s advantages are FDA-approved brand-name medications (Wegovy® pill and pen, Foundayo™, Zepbound®) and help checking insurance coverage. Cora Health’s advantages are a lower month-to-month total for compounded treatment and no separate membership fee.

Market context: where Cora and Ro Body sit in the 2026 GLP-1 telehealth market

Four numbers anchor the head-to-head comparison between Cora Health and Ro Body in 2026:

41.9% — US adult obesity prevalence. Per the Centers for Disease Control and Prevention (CDC), using NHANES 2017–March 2020 data, 41.9% of US adults have obesity (BMI ≥ 30) — the population for whom GLP-1 telehealth was built. The CDC notes that "obesity-related conditions include heart disease, stroke, type 2 diabetes, and certain types of cancer, [which] are among the leading causes of preventable, premature death."

$298 vs $175 — Ro Body vs Cora month-to-month cost (September 27, 2026). Month to month, Ro’s lowest total is $298/month: the $149/month Ro Body membership on its monthly plan plus the Wegovy® pill, an FDA-approved tablet, at $149/month at the 1.5 mg starting dose, rising to $598/month at the highest Zepbound® dose. Cora’s Essential Plan (compounded semaglutide injection) is $175/month on its monthly plan, all-inclusive and renewing automatically. On 12-month terms, Cora’s Essential Plan is $99/month ($1,188 billed upfront every 12 months, prepaid; renews automatically), and Ro’s membership is $74/month prepaid annually, with medication billed separately. This is a compounded-vs-branded comparison: Ro’s medications are FDA-approved; compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Wegovy®. Source: Ro’s pricing page, checked September 27, 2026.

14.9% / 22.5% — results from trials of specific FDA-approved products (Wegovy® 2.4 mg injection in STEP 1, Zepbound® 15 mg in SURMOUNT-1), not of the Wegovy® pill, Foundayo™ or compounded medication. The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks. The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) reported 22.5% with FDA-approved 15mg tirzepatide over 72 weeks. Ro offers FDA-approved Wegovy and Zepbound directly through its own membership platform; Cora is compounded-only. Compounded versions have not been evaluated in these trials. Individual results vary.

~15–20% pharmacy transparency rate. Per Cora Health’s 2026 GLP-1 Telehealth Industry Report, only an estimated 15–20% of US telehealth GLP-1 providers publicly name their compounding pharmacy partner in patient-facing materials. Cora Health publicly names US-licensed 503A compounding pharmacies that prepare its patients’ medication, including Hallandale Pharmacy (PCAB-accredited, Fort Lauderdale FL, operating since 2003) and VialsRx (US-licensed 503A). Ro sells FDA-approved medications only, so the compounding-pharmacy question does not apply to Ro.

Quick comparison at a glance

Ro figures come from Ro’s pricing page, checked September 27, 2026; Ro totals add the Ro Body membership at its monthly-plan rate ($149/month). Cora prices are Cora’s current plan prices: prepaid plans are billed upfront, and every plan renews automatically until you cancel. Individual experiences vary. Compounded medications are not FDA-approved and are not therapeutically equivalent to the FDA-approved medications Ro sells.

Service and cancellation: Cora Health vs Ro

Price is only half the picture — how you cancel, what gets refunded, and whether a separate membership is required all shape the experience over a multi-month plan. The table below distills each platform’s published service terms. Cora’s refund terms are set out in full in its published refund policy; the Ro figures come from its own published terms, summarized in our step-by-step guide to canceling Ro. Verify the current terms on each provider’s own site before enrolling. Cora's full service and cancellation standards are published at trycora.io/service.

How Ro’s pricing actually works

Ro Body uses a two-part pricing structure that is easy to miss from the headline monthly numbers. The figures below are from Ro’s pricing page, checked September 27, 2026.

The first component is the Ro Body membership. It is $39 for the first month, then $149/month on the monthly plan; Ro also sells the membership prepaid, at $99/month every 3 months, $89/month every 6 months, or $74/month for 12 months. Ro says the $39 is refunded if you are not eligible for GLP-1s. Ro describes the membership as including access to GLP-1 medication, a personalized treatment plan, an insurance concierge, provider messaging, regular check-ins, coaching, and lab testing if necessary. The membership does not include the cost of medication.

The second component is the medication, billed separately at cash-pay prices that rise with dose. Ro sells FDA-approved medications only: the Wegovy® pill at $149/month (1.5 mg), $199/month (4 mg), or $299/month (9 mg and 25 mg); the Foundayo™ pill from $149/month (0.8 mg) to $299/month at higher doses; the Wegovy® pen at $199/month for the first two months at 0.25 mg and 0.5 mg (a limited-time price), then $349/month from 1 mg to 2.4 mg, or $399/month at 7.2 mg; and the Zepbound® KwikPen® at $299/month (2.5 mg), $399/month (5 mg), or $449/month (7.5 mg to 15 mg, with a manufacturer offer). Ro says multi-month medication plans can lower these prices by up to 37% on eligible medications.

A patient on the entry-dose Wegovy® pill therefore pays $188 in month one ($39 membership + $149 medication) and $298/month after that on the monthly membership, rising toward $448/month as the dose increases. A patient on the Zepbound® KwikPen® at 7.5 mg or above pays $598/month on the monthly membership ($149 membership + $449 medication). For insured patients, the medication cost may be lower if their insurance covers a brand-name product; Ro offers a free insurance check for Ozempic®, Wegovy® and Zepbound® autoinjector pens.

Why Cora Health’s pricing is different

Cora Health uses an all-inclusive pricing model. The plan price is the full price: there is no separate membership, no consultation charge, no surcharge when the dose increases, and no additional shipping fee. Prepaid plans are billed upfront, and every plan renews automatically until you cancel.

Cora’s Essential Plan (compounded semaglutide):

• 12-month plan: $99/month ($1,188 billed upfront every 12 months, prepaid; renews automatically)
• 6-month plan: $120/month ($720 billed upfront every six months, prepaid; renews automatically)
• 3-month plan: $145/month ($435 billed upfront every three months, prepaid; renews automatically)
• Monthly plan: $175/month (renews automatically)

Cora Health Premium Plan (compounded tirzepatide)

Cora’s Premium Plan follows the same all-inclusive structure.

• 12-month plan: $135/month ($1,620 billed upfront every 12 months, prepaid; renews automatically)
• 6-month plan: $175/month ($1,050 billed upfront every six months, prepaid; renews automatically)
• 3-month plan: $199/month ($597 billed upfront every three months, prepaid; renews automatically)
• Monthly plan: $225/month (renews automatically)

Total cost comparison: common scenarios

Cost depends on which plan and medication each patient selects. Ro figures are from Ro’s pricing page, checked September 27, 2026; Cora figures are Cora’s current plan prices. Each scenario compares the same billing term on both sides, or names the term. Prices may change. Compounded medications are not FDA-approved and are not therapeutically equivalent to the FDA-approved medications Ro sells.

• Compounded semaglutide for 6 months (Cora only — Ro does not sell compounded GLP-1s): $720 billed upfront every six months on the 6-month Essential Plan ($120/month), prepaid; renews automatically.
• Lowest month-to-month totals: Ro $298/month ($149 membership + $149 for the Wegovy® pill, an FDA-approved tablet, at the 1.5 mg starting dose); Cora $175/month for the Essential Plan (compounded semaglutide injection), billed monthly, all-inclusive, renews automatically. They are different products: compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Wegovy®.
• 12-month terms: Cora’s Essential Plan is $99/month ($1,188 billed upfront every 12 months, prepaid; renews automatically). Ro’s 12-month membership is $74/month prepaid annually, and medication is billed separately on top.
• Zepbound® KwikPen® at 7.5 mg or higher, month to month (Ro only): $598/month ($149 membership + $449 medication). Cora Health does not offer Zepbound®.

Medications: what each platform offers

Cora Health focuses exclusively on compounded GLP-1 medications.

• Compounded semaglutide (Essential Plan) — a compounded GLP-1 medication; not FDA-approved and not therapeutically equivalent to Ozempic® or Wegovy®
• Compounded tirzepatide (Premium Plan) — a compounded GLP-1 medication; not FDA-approved and not therapeutically equivalent to Mounjaro® or Zepbound®

Ro offers a broader medication catalog, including FDA-approved brand options

Ro does not sell compounded GLP-1s; its pricing page lists FDA-approved medications only (checked September 27, 2026). Each option requires the Ro Body membership, billed separately. Ro’s weight-loss catalog includes:

• Brand-name Wegovy® pill (FDA-approved oral semaglutide) — $149/month at 1.5 mg, $199/month at 4 mg, $299/month at 9 mg and 25 mg
• Brand-name Foundayo™ pill (FDA-approved orforglipron) — from $149/month at 0.8 mg to $299/month at higher doses
• Brand-name Wegovy® pen (FDA-approved injectable semaglutide) — $199/month for the first two months at 0.25 mg and 0.5 mg (a limited-time price), then $349/month; $399/month at 7.2 mg
• Brand-name Zepbound® KwikPen® (FDA-approved tirzepatide) — $299/month at 2.5 mg, $399/month at 5 mg, $449/month at 7.5 mg to 15 mg (with a manufacturer offer)
• Brand-name Ozempic® and Saxenda® — listed in Ro’s weight-loss menu; its pricing page gives no cash price for them, and Ro offers an insurance check for Ozempic®

Important compliance note on compounded products

Compounded semaglutide and compounded tirzepatide — whether obtained through Cora Health or other telehealth platforms that offer compounded medication — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). Per the U.S. Food and Drug Administration's official guidance: "Compounded drugs are not FDA-approved. This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed." (Source: FDA — "Compounding and the FDA: Questions and Answers".) Clinical efficacy data such as the 14.9% mean weight loss from the STEP 1 trial or the 22.5% from SURMOUNT-1 comes from studies of the FDA-approved formulations, not from compounded versions. Individual results vary. Any platform implying that compounded GLP-1 treatment is equivalent to a branded FDA-approved product is misrepresenting the regulatory status.

Pharmacy transparency: who prepares the medication

For compounded medications, whether a telehealth platform publicly names the specific compounding pharmacy matters as a trust signal. A patient should be able to verify the pharmacy’s state licensing, inspection history, and any third-party accreditation before injecting a medication.

Compounded medication prescribed by licensed providers through Cora Health is prepared by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy, which is PCAB-accredited, and VialsRx. Patients can verify credentials through the relevant state board of pharmacy and request Certificates of Analysis.

Ro does not sell compounded GLP-1s; its pricing page lists FDA-approved medications only (checked September 27, 2026). Those medications are made by their manufacturers — Novo Nordisk for Wegovy and Eli Lilly for Zepbound and Foundayo — so the compounding-pharmacy question does not apply to Ro’s catalog.

Named partnerships are not inherently safer — both named and unnamed 503A pharmacies can operate under full compliance. But public naming makes independent verification easier and is generally viewed by patient advocacy groups as a stronger transparency signal.

Clinical oversight and service model

Cora Health primarily uses asynchronous telehealth evaluations: a patient completes an online health assessment, a licensed provider reviews it, and if appropriate the provider issues a prescription, which is sent to a partner pharmacy for fulfillment.

Cora Health patients are evaluated by a licensed provider at Wasef Health, PC, the medical practice led by Michael Wasef, MD. Provider review is typically completed in under 24 hours.

Ro describes its membership as including provider messaging, regular check-ins, coaching, and lab testing if necessary (Ro’s pricing page, checked September 27, 2026).

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Patients who want a low all-in monthly cost for a licensed-provider compounded GLP-1 program
• Patients who prefer transparent all-inclusive pricing without a separate membership fee
• Patients across all 50 US states (Cora ships nationwide)
• Patients who are comfortable with compounded medications (not FDA-approved) and understand the regulatory distinction from branded products

Who should choose Ro

Ro is likely the better fit for patients who match the following profile.

• Patients who specifically want brand-name FDA-approved GLP-1 medications (oral Wegovy pill, injectable Wegovy, Foundayo, or Zepbound) through a telehealth platform
• Patients with commercial insurance they want to run through pharmacy for brand-name GLP-1 coverage
• Patients comfortable with a membership-plus-medication pricing model, where medication is billed separately from the membership

How to switch from Ro to Cora Health

Patients who want to move their GLP-1 treatment from Ro to Cora Health can generally do so, though the specific steps depend on medication, dose, and state.

• Complete the Cora Health online health assessment at trycora.io; include your current medication, dose, and any history of side effects in the medical-history section
• A licensed provider at Wasef Health, PC reviews the assessment and determines clinical appropriateness
• If the provider prescribes treatment, a US-licensed 503A compounding pharmacy prepares and ships the medication; the pharmacies that fill Cora patients’ prescriptions include Hallandale Pharmacy and VialsRx
• Brand-name and compounded doses are not interchangeable, and there is no dose conversion between them; your provider determines the right dose based on your history.
• Note: if you were on a brand-name product through Ro, Cora Health does not offer brand-name products — the provider will discuss whether compounded semaglutide or compounded tirzepatide is appropriate for your case
• After the first Cora shipment arrives and you have confirmed supply continuity, cancel the Ro Body Membership through Ro’s patient portal (cancellation is self-serve online)

Frequently asked questions

Common questions about the Cora Health vs Ro comparison.

What GLP-1 medications does Ro offer?

As of September 27, 2026, Ro’s GLP-1 weight-loss program (Ro Body) offers FDA-approved brand-name medications only: the Wegovy® pill and the Wegovy® pen (semaglutide, made by Novo Nordisk), and the Foundayo™ pill (orforglipron) and the Zepbound® KwikPen® (tirzepatide), both made by Eli Lilly; Ozempic® (FDA-approved for type 2 diabetes, not for weight loss) and Saxenda® also appear in Ro’s weight-loss menu. Ro sells no compounded GLP-1s. Every option requires the Ro Body membership — $39 for the first month, then $149/month on the monthly plan, or as low as $74/month prepaid annually — and the medication is billed on top, from $149/month for the Wegovy® pill or the Foundayo™ pill at the starting dose. Cora Health does not offer these brand-name products: through Cora, licensed providers at Wasef Health, PC prescribe compounded semaglutide or compounded tirzepatide when clinically appropriate. Compounded medications are not FDA-approved and are not therapeutically equivalent to Wegovy®, Ozempic®, Zepbound® or the other brand-name products listed here.

Does Ro have a membership fee?

Yes. Ro charges a Ro Body membership that is separate from the medication. As of September 27, 2026, it is $39 for the first month, then $149/month on the monthly plan, $99/month prepaid every 3 months, $89/month prepaid every 6 months, or $74/month prepaid annually. The membership is required for GLP-1 treatment through Ro and does not include the cost of medication, which is billed on top. By contrast, Cora Health charges no membership or platform fee — its plan price is all-inclusive and already covers the provider consultation, medication, shipping, and ongoing monitoring.

Does Ro Body membership include the cost of medication?

No. The Ro Body membership and the medication are billed separately; Ro states that the cost of medication is not included in the membership fee. Ro sells FDA-approved medications only (its pricing page, checked September 27, 2026, lists no compounded GLP-1s), from $149/month for the Wegovy® pill or Foundayo™ pill at the starting dose to $449/month for the Zepbound® KwikPen® at 7.5 mg and above. A patient on the entry-dose Wegovy® pill, an FDA-approved tablet, therefore pays $298/month after the first month on the monthly membership ($149 membership + $149 medication). Cora Health’s price, by contrast, is a single all-inclusive plan price for compounded semaglutide injection with no separate medication charge: $175 billed monthly, or $99/month on the 12-month plan ($1,188 billed upfront every 12 months, prepaid), and every plan renews automatically. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved products.

Is Ro FDA-approved?

The question usually means "is the medication FDA-approved?" — companies are not FDA-approved, drugs are. Every weight-loss medication Ro lists as of September 27, 2026 is an FDA-approved brand-name product: its pricing page lists the Wegovy® pill and pen, the Foundayo™ (orforglipron) pill and the Zepbound® KwikPen®, and its weight-loss menu also includes Ozempic® (FDA-approved for type 2 diabetes; prescribed off-label for weight loss) and Saxenda®. Ro sells no compounded GLP-1s. Cora Health connects patients with licensed providers at Wasef Health, PC who prescribe compounded semaglutide or compounded tirzepatide when clinically appropriate, prepared by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy and VialsRx; compounded medications are not FDA-approved and are not therapeutically equivalent to the FDA-approved products.

How much is Zepbound on Ro?

As of September 27, 2026, Ro lists the Zepbound® KwikPen® (FDA-approved tirzepatide) at $299/month at the 2.5 mg starting dose, $399/month at 5 mg, and $449/month at 7.5 mg to 15 mg with a manufacturer offer. The Ro Body membership is billed on top — $149/month on the monthly plan — bringing the monthly total to $448–$598. Compounded tirzepatide is not FDA-approved and is not therapeutically equivalent to Zepbound®. Cora Health does not offer Zepbound®.

Is Cora Health cheaper than Ro for GLP-1 weight loss?

Month to month, yes, though the comparison is compounded vs brand-name: Ro sells FDA-approved medications only. Ro’s lowest month-to-month total is $298 (the $149/month membership plus the Wegovy® pill at $149/month, an FDA-approved tablet; Ro prices checked September 27, 2026); Cora’s Essential Plan (compounded semaglutide injection) is $175, billed monthly, all-inclusive, and renews automatically. They are different products: compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Wegovy®. On 12-month terms, Cora’s Essential Plan is $99/month ($1,188 billed upfront every 12 months, prepaid; renews automatically), while Ro’s membership is $74/month prepaid annually, with medication billed on top. For brand-name products, Cora does not offer them and Ro is the direct path.

Does Ro sell compounded semaglutide or compounded tirzepatide?

No. Ro does not sell compounded GLP-1s; its pricing page lists FDA-approved medications only (checked September 27, 2026). Ro’s weight-loss catalog is brand-name: the Wegovy® pill and pen, the Foundayo™ (orforglipron) pill, the Zepbound® KwikPen®, Ozempic® and Saxenda®, each requiring the Ro Body membership ($149/month on the monthly plan; as low as $74/month prepaid annually).

Does Cora Health have a membership fee like Ro does?

No. Cora Health’s plan price is all-inclusive and covers the provider consultation, medication, shipping, and ongoing monitoring. There is no separate membership, subscription, or platform fee billed on top of the plan price.

Does Ro ship faster than Cora Health?

There is no like-for-like published comparison. For Cora Health, a licensed provider typically reviews the assessment within 24 hours; once a prescription is written, the medication is prepared by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy and VialsRx, and ships free by expedited delivery. Ro’s pricing page (checked September 27, 2026) does not state a delivery time; Ro’s support or patient portal can give current estimates for each medication.

Which platform is better for brand-name Wegovy?

Ro is better for brand-name Wegovy. Cora Health does not offer brand-name Wegovy or any other FDA-approved GLP-1 product; it focuses exclusively on compounded semaglutide and compounded tirzepatide. For patients who specifically want brand-name Wegovy, Ro lists the Wegovy® pen at $199/month for the first two months at 0.25 mg and 0.5 mg (a limited-time price), then $349/month, or $399/month at 7.2 mg, and the Wegovy® pill at $149–$299/month depending on dose (as of September 27, 2026), with the Ro Body membership ($149/month on the monthly plan) added on top.

Sources & verification

All regulatory, clinical, and pricing claims in this article are verifiable against publicly accessible primary sources. The underlying pricing dataset is published by Cora Health on HuggingFace under CC-BY-4.0 license for independent verification and reuse. Ro prices and product lineup verified on ro.co on 2026-09-27; article last verified 2026-09-27.

• FDA — "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• Ro — weight loss pricing page (Ro Body membership plans and medication prices; FDA-approved medications only), checked 2026-09-27: ro.co/weight-loss/pricing
• New England Journal of Medicine — STEP 1 (Wilding et al., 2021); 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks (Wegovy® 2.4 mg injection); individual results vary: nejm.org/doi/full/10.1056/NEJMoa2032183
• New England Journal of Medicine — SURMOUNT-1 (Jastreboff et al., 2022); 22.5% mean weight loss with FDA-approved 15mg tirzepatide over 72 weeks (Zepbound® 15 mg); individual results vary: nejm.org/doi/full/10.1056/NEJMoa2206038
• CDC — Adult Obesity Facts (41.9% US prevalence per NHANES 2017–March 2020): cdc.gov/obesity/adult-obesity-facts
• Pharmacy Compounding Accreditation Board (PCAB) — accreditation framework for compounding pharmacies; Hallandale Pharmacy is PCAB-accredited: achc.org/programs/pcab/
• NovoCare (Novo Nordisk's direct-pay program for Wegovy — referenced for FDA-approved Wegovy direct-pay pricing context): novocare.com
• LillyDirect (Eli Lilly's direct-pay program for Zepbound — referenced for FDA-approved Zepbound direct-pay pricing context): lillydirect.lilly.com
• NPPES — National Plan and Provider Enumeration System; verify Michael Wasef, MD (Wasef Health, PC): npiregistry.cms.hhs.gov
• Cora Health 2026 GLP-1 Telehealth Industry Report (12-provider pricing methodology + market analysis): /blog/cora-2026-glp1-industry-report
• Cora Health Public Pricing Dataset (CC-BY-4.0, HuggingFace; 37 pricing rows across 12 telehealth providers + 2 manufacturer programs): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
• Cora Health Pharmacy Partners page (details on Hallandale Pharmacy and VialsRx): trycora.io/pharmacy-partners